DUSP1 and leukemia: Another study showed that the enhanced MAPK signaling resulted in dependence on dual specificity phosphatase 1 (DUSP1) that augmented survival signaling, and further that combined use of a DUSP1 inhibitor in concert with trametinib eradicated leukemia [126].